Panacea Biotec

Narayana Hrudayalaya To Acquire Panacea Biotec Arm For Rs 180 Crore

Business | Press Trust of India | Friday April 21, 2017

This transaction is intended to consolidate Narayana Hrudayalaya's footprint in the northern cluster.

Panacea Biotec Surges 7% As FDA Clears Solan Facility

Business | Monday November 21, 2016

Shares of Panacea Biotec surged as much as 6.76 per cent to hit intraday high of Rs 112.80 in an otherwise weak market after the US drug regulator (USFDA) gave its Establishment Inspection Report (EIR) for the Indian drugmaker's facilities in Solan, Himachal Pradesh.

Panacea Biotec Launches Diabetes Drug

Business | Press Trust of India | Tuesday June 28, 2016

Drug firm Panacea Biotec has launched diabetes drug 'Tenepan', used for treating Type 2 Diabetes Mellitus, in the country.

Panacea Biotec posts net profit of Rs 83 crore in Q3

Business | Thursday February 13, 2014

Panacea Biotec on Thursday posted a net profit of Rs 82.79 crore for the third quarter that ended on December 31, 2013.

Panacea to scale up anti-cancer production, starts new plant

Business | Wednesday March 28, 2012

Drug firm Panacea Biotec said it is scaling up production of anti-cancer products with the commissioning of its new facility at Baddi in Himachal Pradesh set up at an investment of Rs 55 crore.

PANACEA BIOTEC LTD. - Outcome of AGM

Business | NDTV Correspondent | Saturday November 26, 2011

Panacea Biotec Ltd has informed BSE that 27th Annual General Meeting (AGM) of the Company was held on September 24, 2011.

PANACEA BIOTEC LTD. - Fixes Book Closure for Dividend & AGM

Business | NDTV Correspondent | Saturday November 26, 2011

Panacea Biotec Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 21, 2011 to September 24, 2011 (both days inclusive) for the purpose of Payment of Dividend & 27th Annual General Meeting (AGM) of the Company to be held on September 24, 2011. The dividend shall be paid/d...

PANACEA BIOTEC LTD. - Limited Review for the quarter ended June 30, 2011

Business | NDTV Correspondent | Saturday November 26, 2011

Panacea Biotec Ltd has informed BSE that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended June 30, 2011.

Stocks Pulse: Panacea Biotec up 2% on margin improvement in Apr-Jun

Business | NDTV Correspondent | Friday November 25, 2011

MUMBAI, JULY 21: Shares of Panacea Biotec were up 2% after the company reported improved margins in its formulations as well as vaccines businesses. Net profit in Apr-Jun was Rs 326 million, up 151% from a year ago. "Improved margins from the formulations and vaccines segments have boosted the net profit," said Manoj Garg, analyst at Emkay Shar...

Panacea Biotec recommends dividend

Business | NDTV Correspondent | Friday November 25, 2011

Of 25%The board of Panacea Biotec in its meeting on 07 May 2010 has recommended dividend at the rate of Re. 0.25 (25%) for the financial year 2009-10.

Panacea Biotec reports net profit of Rs 57.52 crore in the March 2010 quarter

Business | NDTV Correspondent | Friday November 25, 2011

Sales rise 37.61% to Rs 313.25 crorePanacea Biotec reported net profit of Rs 57.52 crore in the quarter ended March 2010 as against net loss of Rs 40.17 crore during the previous quarter ended March 2009. Sales rose 37.61% to Rs 313.25 crore in the quarter ended March 2010 as against Rs 227.63 crore during the previous quarter ended March 2009.For ...

Panacea Biotec to announce financial results

Business | NDTV Correspondent | Friday November 25, 2011

Board meeting on 07 May 2010 The board meeting of Panacea Biotec will be held on 07 May 2010 to consider and approve the audited financial results for the financial year 2009-10 and to recommend dividend, if any.

Panacea Biotec spurts after US nod for formulations unit

Business | NDTV Correspondent | Friday November 25, 2011

Panacea Biotec jumped 7.01% to Rs 228.85 at 10:43 IST on BSE, after the company got US Food & Drug Administration approval for its pharmaceutical formulation facility at Baddi in Himachal Pradesh.The company made this announcement during trading hours today, 30 April 2010.Meanwhile, the BSE Sensex was up 133.7 points, or 0.76% to 17,637.24.On BSE, ...

Panacea Biotec receives USFDA approval

Business | NDTV Correspondent | Friday November 25, 2011

For its pharmaceutical formulation facility at Baddi in Himachal PradeshPanacea Biotec has received approval from US Food and Drug Administration (USFDA) for its pharmaceutical formulation facility at Baddi in Himachal Pradesh.The company made this announcement during the trading hours today, 30 April 2010.

Panacea Biotec wins financial assistance award for PandyFlu

Business | NDTV Correspondent | Friday November 25, 2011

The government on Friday said direct tax collection has surpassed the budget estimate of Rs 3.70 lakh crore for the 2010 fiscal.